Introduction
============

SUMOylation is a posttranslational modification that consists of the covalent and reversible binding of the Small Ubiquitin--like MOdifier, SUMO, to a target protein. This interaction can modify the properties of target proteins affecting their localization, activity, or stability. Protein SUMOylation is involved in many cellular processes, such as cell cycle progression, transcription, nucleocytoplasmic transport, apoptosis, and genome integrity and stability ([@msv242-B18]; [@msv242-B17]). As these processes are essential for normal animal development, the study of SUMOylation and its mechanisms of action are of paramount importance.

SUMO proteins are translated as immature precursors and subsequently converted to their mature forms through the activity of sentrin/SUMO-specific proteases (SENPs). Then, mature SUMO is transferred to target proteins through a number of well-defined steps. First, the E1 activating enzyme (SAE1/SAE2) activates SUMO, which can subsequently be recognized and attached to the UBC9 E2-conjugating enzyme. UBC9 mediates covalent interaction of SUMO to the target protein, although the participation of some E3-ligases, which help with substrate recognition, can be also required ([@msv242-B17]). The interaction between SUMO and the target protein is a reversible process, as SUMO can be detached through the action of some SENPs. SUMOylation usually occurs at lysine residues in the consensus ΨKxD/E motif, but not all such lysines become SUMOylated and, in some cases, SUMO can also attach to lysine residues outside of this motif ([@msv242-B56]).

The number of *SUMO* paralogs varies depending on the species. For example, the yeast *Saccharomyces cerevisae*, the nematode *Caenorhabditis elegans* and the insect *Drosophila melanogaster* have only one *SUMO* gene, whereas plants and vertebrates contain several. Humans have four *SUMO* paralogs (*SUMO1--4*). Human SUMO2 and 3 share 97% identity at the amino acid level and comprise the SUMO2/3 subfamily. In contrast, human SUMO1 shares only approximately 50% identity with SUMO2/3. Finally, SUMO4 shares 87% identity with SUMO2, but its activation and conjugation has not been demonstrated ([@msv242-B55]). Consistent with their sequence differences, SUMO1 and SUMO2/3 usually conjugate to different substrates, but the functional relevance of such specificity remains poorly understood. Vertebrate paralogs also differ in their ability to form polySUMO chains, as SUMO2/3 can be SUMOylated and form chains, whereas SUMO1 cannot and may serve as chain terminator ([@msv242-B34]). PolySUMO chains are functionally important for cellular stress response and degradation of damaged proteins ([@msv242-B43]; [@msv242-B8]). Because of these key functions, polySUMO chain formation represents an active area of research, although it has only been described in human and yeast.

In insects, SUMOylation has been studied in highly derived holometabolous species, particularly in the dipteran *Drosophila melanogaster.* In this organism, which has a single *SUMO* gene (*smt3*), SUMOylation is required in many developmental processes, such as embryogenesis, wing morphogenesis, nervous system development, immune response, apoptosis, and metamorphosis ([@msv242-B47]). Although one might assume that all insects harbor a single *SUMO* gene, our data and recent genome sequencing efforts reveal that more basal insect species have two *SUMO* paralogs. In this study, by using the hemimetabolous cockroach *Blattella germanica* as a model insect with two *SUMO* genes (*SUMO1* and *SUMO3*), we examine the characteristics and different biological functions of the two *Blattella SUMO* paralogs to explore the evolutionary consequences of the loss of one *SUMO* gene during insect evolution. In addition to the study of the paralog-specific functions of SUMO proteins in species with more than one *SUMO* gene, our work has focused on the requirements and functions for polySUMO chain formation in insects. Here, we report that SUMO1, but not SUMO3, specifically controls different key processes in *Blattella* metamorphosis, such as cell proliferation, ecdysone biosynthesis and signaling response to this hormone, developmental timing, and proper molting. In contrast, we show that SUMO1 and SUMO3 exert redundant functions in *Blattella* viability. Finally, we show that, in contrast to vertebrates, insect SUMO proteins cannot form polySUMO chains.

Results and Discussion
======================

Insects Lost the *SUMO1* Paralog during Evolution
-------------------------------------------------

As mentioned above, SUMOylation has been studied in insects that contain a single *SUMO* gene, particularly *Drosophila* ([@msv242-B47]). However, a detailed analysis of *SUMO* paralogs in the insect genomes reported in the databases shows that insects present one or two *SUMO* genes. To determine when, during evolution, insects gained and/or lost *SUMO* genes, we performed a phylogenetic analysis using all insect *SUMO* sequences available, as well as those of human and mouse as representatives of the vertebrate group. The multiple sequence alignment and the posterior phylogenetic tree obtained grouped *SUMO* sequences in two differentiated clusters with a bootstrap support value of 100% (for a total of 100 iterations) ([fig. 1](#msv242-F1){ref-type="fig"}*A*). The upper part of the tree grouped the insect sequences similar to vertebrate *SUMO1*, whereas the rest of the insect sequences grouped with the vertebrate *SUMO2/3* subfamily in the lower branch of the tree. The analysis of the phylogenetic tree shows that Coleopteran, Lepidopteran, and Dipteran species contain only one *SUMO* gene, orthologous to human *SUMO2/3.* Conversely, Hymenopteran and all Hemimetabolan species contain two *SUMO* genes that are orthologous to human *SUMO1* and *SUMO2/3* genes. Therefore, according to the insect phylogeny currently accepted ([@msv242-B36]), our phylogenetic analysis strongly suggests that insects lost the *SUMO1* paralog after the Hymenoptera divergence. Interestingly, it was previously thought that the duplication of the ancestral *SUMO* gene into two subfamilies, *SUMO1* and *SUMO2/3*, had occurred in the subphylum Vertebrata ([@msv242-B45]). However, the presence in basal insects of *SUMO1* and *SUMO3* paralogs suggests that *SUMO* gene duplication occurred earlier during animal evolution. Consistent with this hypothesis, a new phylogenetic analysis using *SUMO* sequences available from species representative of different eukaryotic groups confirmed that the duplication between *SUMO1* and *SUMO3* occurred at the base of the Metazoa and that later in Metazoan evolution *SUMO* genes were secondarily lost in different lineages and specifically expanded in vertebrates ([supplementary fig. S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). F[ig]{.smallcaps}. 1.Insects lost the *SUMO1* paralog after the hymenopteran divergence. (*A*) Phylogenetic analysis of insect *SUMO* proteins. Human and mouse *SUMO* sequences were included as reference. Branch lengths are proportional to sequence divergence. The bar represents 0.2 substitutions per site. Only bootstrap values ≥50% are shown. EMBL accession number for each sequence is included in parentheses. Color code refers to Hemimetabola (blue), Hymenoptera (green), Coleoptera (purple), Diptera and Lepidoptera (red), and human and mouse (orange). (*B*) Superposition of the structures of *Drosophila* Smt3 (magenta), human SUMO2 (green), and human SUMO3 (cyan). The protein backbones are depicted as ribbons showing the different secondary structure elements. The N- and C-terminal ends of the chains, labeled in the figure, were disordered and flexible in solution, and the superposition was based on the well-ordered chain segments. (*C*) Sequence alignment of the indicated SUMO proteins. The numbers and the secondary structure elements indicated above the sequences correspond to *Drosophila* Smt3. Arrows are indicative for β-strands, spirals for α-helices (α) and 3~10~ helices (η), and "T" for turns. Conserved regions in all sequences are marked in magenta. Lysine groups being part of SUMOylation consensus sites (underlined) are highlighted in green.

Insect SUMO3 Paralogs Do Not Form SUMO Chains
---------------------------------------------

The fact that SUMOylation in insects has been only studied in species with a single *SUMO* gene raises questions about a specific role for the *SUMO* paralog lost during insect evolution. To address this question, we decided to characterize the SUMOylation process in a hemimetabolous insect model. With a well-characterized postembryonic development, including the metamorphic period, and an efficient and systemic RNA interference (RNAi) response ([@msv242-B33]; [@msv242-B52]), *Blattella germanica* is a suitable model to study SUMOylation in an insect with two *SUMO* genes. To this end, we first cloned the two *SUMO* sequences of *Blattella* from a cDNA library synthesized from embryonic cells (UM-BGE-1 cell line). Based on their similarity with the *SUMO* sequences described, we named them *BgSUMO1* (EMBL: LN809887) and *BgSUMO3* (EMBL: LN809888) ([fig. 1](#msv242-F1){ref-type="fig"}*A* and [supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Sequence alignment of the human, *Blattella*, and *Drosophila SUMO* sequences, along with the comparison of the available SUMO structures, reveals high sequence and structure similarities in the central region of the proteins and higher divergence in the N- and C-terminal parts, which are flexible and structurally disorganized ([fig. 1](#msv242-F1){ref-type="fig"}*B* and *C*). Furthermore, the N-terminal part of BgSUMO1 presents high similarity with human SUMO1, whereas the N-terminal part of BgSUMO3 shows higher similarity with DmSmt3 than with human SUMO3 ([fig. 1](#msv242-F1){ref-type="fig"}*C*).

Interestingly, a detailed analysis of the insect SUMO sequences revealed the absence of SUMOylation consensus sites in *Drosophila* Smt3 and *Blattella* BgSUMO3 proteins and only a low probability SUMOylation site (QK^8^PD) in BgSUMO1 ([fig. 1](#msv242-F1){ref-type="fig"}*C*). In contrast, human SUMO2/3 proteins present a SUMOylation consensus site (VK^11^TE) that is able to form polySUMO chains in vivo, and two nonconsensus lysine residues with lower SUMO affinity (EK^5^PK and SK^42^LM) ([@msv242-B26]; [@msv242-B34]; [@msv242-B4]) ([fig. 1](#msv242-F1){ref-type="fig"}*C*). Moreover, human SUMO1 contains one low probability SUMOylation site (DK^16^KE) that is SUMOylated only when large amounts of the Ubc9 enzyme are added in vitro ([@msv242-B34]) ([fig. 1](#msv242-F1){ref-type="fig"}*C*). Taken together, these data suggest that, in contrast to human proteins, insect SUMO paralogs cannot form polySUMO chains. To test this possibility, we studied the ability of BgSUMO1, BgSUMO3, and Smt3 to be SUMOylated in vitro. As a positive control of strong SUMOylation we used human SUMO3, whereas human SUMO1 was used as a control for residual in vitro SUMOylation. First, we generated hemagglutinin (HA)-tagged forms of the different SUMO proteins and incubated them with recombinant human SUMO2/3 and the proteins of the conjugation machinery (SAE1/2 and Ubc9). These HA-tagged SUMO forms lack the two glycine residues involved in SUMO conjugation and, therefore, can be SUMOylated but not attached to target proteins. Confirming that the system works properly, we detected that human SUMO3 was strongly modified by SUMO2/3 ([fig. 2](#msv242-F2){ref-type="fig"}*A*), as it was previously described ([@msv242-B26]; [@msv242-B34]; [@msv242-B4]). Consistent with our hypothesis, *Drosophila* Smt3 and BgSUMO3 were not able to form polySUMO chains and, based on the degree of SUMOylation of human SUMO1, only residual SUMOylation was observed for *Blattella* BgSUMO1 ([fig. 2](#msv242-F2){ref-type="fig"}*A*). As human SUMO1 is not considered to be SUMOylated in vivo despite its modest capacity to be SUMOylated in vitro ([@msv242-B34]), our results indicate that none of the insect SUMO paralogs can form polySUMO chains. F[ig]{.smallcaps}. 2.Insect SUMO proteins do not form polySUMO chains in vitro. (*A*) In vitro SUMOylation assay for *Blattella* BgSUMO1 and BgSUMO3, *Drosophila* Smt3, and human SUMO1 (negative control) and SUMO3 (positive control). HA-tagged forms of all proteins were incubated in the absence (−) or presence (+) of human SUMO2/3. Arrowheads indicate the modified proteins, whereas asterisk indicates unspecific bands. Molecular weight markers are shown to the left. (*B*) Residue composition of the chimera *S3/Smt3*, which has the initial 14 amino acids from human SUMO3 (magenta) and the rest of the protein corresponding to *Drosophila* Smt3 (cyan). In the chimera *S3(K11R)/Smt3*, K11 has been mutated to R. (*C*) In vitro SUMOylation assay for the human SUMO3/*Drosophila* Smt3 chimeric proteins, either WT (S3/Smt3) or mutant for K11 (S3(K11R)/Smt3. Arrowheads indicate the modified proteins. (*D*) Detection of SUMO chains formed in vitro through SUBEs. Bracket indicates polySUMO-chains formed and asterisk indicates unspecific bands.

SUMOylation of human SUMO3 in vivo has been preferentially observed on lysine11 (K11) ([@msv242-B34]). In *Saccharomyces*, Smt3 SUMOylation can also occur in lysine residues located at the N-terminal part of the protein (K11, K15, and K19) ([@msv242-B7]). To further confirm that insect SUMO3 proteins were not SUMOylated by the absence of critical lysine residues in the N-terminal part of their sequences ([figs. 1](#msv242-F1){ref-type="fig"}*C* and 3), we created a chimeric SUMO protein consisting of methionine1-asparagine14 (M1-N14) residues of human SUMO3 (containing K11) and residues glutamic acid11-threonine86 (E11-T86) of *Drosophila* Smt3 (S3/Smt3) ([fig. 2](#msv242-F2){ref-type="fig"}*B*). Under these conditions, the in vitro analysis confirmed the SUMOylation of the chimeric protein, indicating that the N-terminal region of SUMO proteins is critical to form chains ([fig. 2](#msv242-F2){ref-type="fig"}*C*). In addition, the mutation of K11 to arginine11 (R11) (S3(K11R)/Smt3) completely abolished the polySUMOylation ability of the chimeric protein, further demonstrating the essential role of K11 for SUMO chain formation ([fig. 2](#msv242-F2){ref-type="fig"}*C*). We confirmed these results by using the recently developed SUMO-traps or SUBEs (SUMO-binding entities), which specifically interact with polySUMO chains ([@msv242-B15]), to isolate the SUMO chains formed in vitro ([fig. 2](#msv242-F2){ref-type="fig"}*D*). Consistent with the SUMOylation assay, SUBEs recognized chain formation when human SUMO3 or the chimeric S3/Smt3 was used as substrates, but not when *Drosophila* Smt3 or the chimeric mutant S3(K11R)/Smt3 was used ([fig. 2](#msv242-F2){ref-type="fig"}*D*). Overall, these results confirm that, in contrast to vertebrates, *Drosophila* and *Blattella* SUMO3 paralogs have lost the capacity to form polySUMO chains, as they have lost the SUMOylation domains in the N-terminal part of their sequences. Remarkably, a detailed analysis of the N-terminal region of SUMO3 sequences in eukaryote organisms reveals that all insects and crustaceans (Pancrustacea) reported to date have lost the SUMOylation consensus sites ([fig. 3](#msv242-F3){ref-type="fig"}). These data suggest that 1) the presence of the SUMOylation domain in the N-terminal part of the SUMO3 protein is an ancestral character of this protein, and 2) this sequence has been lost in Pancrustacea, thus rendering SUMO proteins of insects unable to form polySUMO chains. As all insect SUMO1 proteins do not present SUMOylation domains in their N-terminus either ([fig. 3](#msv242-F3){ref-type="fig"}), our result suggests that insect SUMO proteins cannot be SUMOylated. F[ig]{.smallcaps}. 3.Insect SUMO proteins lack SUMOylation consensus motifs. Sequence alignment of the N-terminal region of SUMO proteins. Conserved regions in all sequences are marked in magenta. High- and low-probability SUMOylation consensus sites are highlighted in green or yellow, respectively. K5 and K11 residues within the SUMOylation consensus sites in human SUMO2/3 sequences are highlighted in black.

SUMOylation Is Essential for *Blattella* Metamorphosis
------------------------------------------------------

To study the biological functions of the two SUMO paralogs in *Blattella*, we first analyzed their spatial and developmental expression patterns. Both *BgSUMO* mRNAs were present in all tissues analyzed, namely the fat body, epidermis, ovary, brain, *corpora allata*, digestive tract, and prothoracic glands ([supplementary fig. S2*A*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Given that both genes are ubiquitously expressed, we analyzed the mRNA levels of *BgSUMO1* and *BgSUMO3* in the prothoracic gland, as a model tissue, and found that both were expressed throughout development ([supplementary fig. S2*B*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Next, we used systemic RNAi to examine the role of *SUMO* genes in *Blattella*. We focused our functional analysis on the metamorphosis of *Blattella*, as it has been shown that *Drosophila* Smt3 has essential roles in the metamorphic process ([@msv242-B47]). In *Blattella*, metamorphosis occurs during the last nymphal instar stage (N6) and is mainly characterized by the appearance of functional wings ([@msv242-B30]). First, we lowered the expression of both *BgSUMO* genes by injecting simultaneously two *dsRNAs* targeting each *BgSUMO* transcript in newly emerged N5 female nymphs (herein called *BgSUMO1-3i* animals) to ensure the depletion of both *BgSUMO*s during the metamorphic stage ([supplementary fig. S2*C*--*E*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Specimens injected with *dsMock* were used as negative controls (*Control* animals). All *BgSUMO1-3i* nymphs molted into N6 six days after injection, as the *Control* animals ([supplementary table S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). However, *BgSUMO1-3i* nymphs died 1--4 days after the N6 molt, thus precluding the functional analysis of SUMO proteins during metamorphosis ([fig. 4](#msv242-F4){ref-type="fig"}*A* and [supplementary table S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). To circumvent this problem, we injected the *dsRNA* into newly emerged N6 female nymphs. Under this condition, the majority of *BgSUMO1-3i* nymphs molted into adults although showing a significant delay of approximately 1 day compared with *Control* animals ([fig. 4](#msv242-F4){ref-type="fig"}*A* and [supplementary table S3](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). As before, all *BgSUMO1-3i* adults died 1--4 days after the imaginal molt, confirming that SUMOylation is essential for *Blattella* viability. A similar role in viability has been described in a wide range of species, such as *Drosophila, Saccharomyces*, *Caenorhabditis*, *Danio rerio,* or *Mus musculus* ([@msv242-B16]; [@msv242-B22]; [@msv242-B23]; [@msv242-B37]; [@msv242-B39]; [@msv242-B21]). Interestingly, *BgSUMO1-3i* adults presented clear deficiencies in the extension of the wings and malformations in the leg bristles, indicative of molting problems ([fig. 4](#msv242-F4){ref-type="fig"}*B* and *C*). They also showed a significant reduction in the size of the fore- and hindwings ([fig. 4](#msv242-F4){ref-type="fig"}*D*), suggesting impairment of cell proliferation during metamorphosis. To further study whether SUMOylation is required for cell proliferation during metamorphosis, we analyzed the increase of follicular epithelial cells that surround basal oocytes. These cells proliferate intensively during the metamorphic nymphal stage from approximately 500 cells in newly ecdysed N6 nymphs to approximately 3,500 cells just before the imaginal molt ([@msv242-B31]). As [figure 4](#msv242-F4){ref-type="fig"}*E* shows, depletion of both *BgSUMO*s dramatically impaired the proliferative activity of follicular cells as revealed by a temporal analysis of cell division by phospho-Histone H3 (pH3) staining. We also analyzed whether the absence of *BgSUMO*s induces cell death by immunostaining the follicular cells with anti-activated-caspase-3 antibody. We did not detect any increase in cell death in the *BgSUMO1-3i* animals ([supplementary fig. S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). As a result, the number of the follicular cells was significantly reduced in *BgSUMO1-3i* animals, confirming that SUMOylation is required for cell proliferation during *Blattella* metamorphosis ([fig. 4](#msv242-F4){ref-type="fig"}*F*). The role of SUMOylation in cell cycle progression and tissue proliferation has been demonstrated in other eukaryotic organisms, indicating its conserved function ([@msv242-B37]; [@msv242-B40]; [@msv242-B39]; [@msv242-B27]; [@msv242-B50]; [@msv242-B24]). In *Drosophila*, for example, many proteins involved in cell division are SUMOylated, such as PCNA, RFC2, Topoisomerase I, Topoisomerase II, and Polo ([@msv242-B38]). In addition to the proliferation impairment, the nuclei of the follicular cells of *BgSUMO1-3i* animals were bigger and presented an abnormal shape compared with *Control* nuclei ([fig. 4](#msv242-F4){ref-type="fig"}*F*). Similarly, SUMOylation-deficient mice and zebrafish embryos also present abnormal nucleus morphology due to aberrant sister chromatid separation, hypocondensation, and polyploidy ([@msv242-B37]; [@msv242-B39]). F[ig]{.smallcaps}. 4.SUMOylation controls *Blattella* metamorphosis and developmental timing. (*A*) Representation of the timing of imaginal molt in *Control* (blue), *BgSUMO1-3i* animals injected in N5 (green), and *BgSUMO3i* animals injected in N6 (red). (*B*) Dorsal view of a Control specimen 1 day after the imaginal molt, showing a normal winged adult shape (left), and a *BgSUMO1-3i* adult showing defects on wing extension in both the forewings and hindwings (right). Scale bar: 2 mm. (*C*) Detail of the adult bristles in *Control* and *BgSUMO1-3i* individuals. Scale bar: 0.2 mm. (*D*) Forewings (left) and hindwings (right) in newly molted *Control* and *BgSUMO1-3i* adults. Scale bars: 2 mm. Means of maximum length and width of forewings (bottom left) and hindwings (bottom right) in *Control* and *BgSUMO1-3i* adults. Error bars represent SEM (*n* = 5). Asterisks indicate differences statistically significant as follows: \*\*\**P* ≤ 0.0005 (*t*-test). (*E*) Graphical representation of the mitotic capacity of follicular cells in 5- and 6-day-old *Control* (gray bars), *BgSUMO1-3i* (red bars), and *BgSUMO1-3i* N6 nymphs treated with the edysteroid hormone 20E (yellow bars), represented by the number of nuclei marked by the mitotic marker PH3. Asterisks indicate differences statistically significant as follow: \*\**P* \< 0.001; \*\*\**P* \< 0.0001 (*n* = 25--30). (*F*) DAPI staining and follicular cell number from basal oocytes in newly molted *Control*, *BgSUMO1-3i,* and *BgSUMO1-3i* adults treated with 20E. Scale bar: 5 μm. Error bars represent SEM (*n* = 5--15). Asterisks indicate differences statistically significant as follows: \*\*\**P* ≤ 0.0005 (*t*-test).

To further confirm that the phenotype of *BgSUMO1-3i* animals was due to the impairment of SUMOylation, we cloned and depleted by RNAi the SUMO-conjugating enzyme *BgUbc9* (*BgUbc9i* animals) ([supplementary fig. S3*B*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). As both *BgSUMO*s, *BgUbc9* mRNA was present throughout development ([supplementary fig. S3*A*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Like *BgSUMO1-3i* animals, *BgUbc9*-depleted nymphs molted into adults showing clear morphological deficiencies in the legs and the spreading of the wings ([fig. 5](#msv242-F5){ref-type="fig"}*A* and *B*). They also showed a significant reduction in the size of the fore- and hindwings and in the number of follicle cells ([fig. 5](#msv242-F5){ref-type="fig"}*C* and *D*). Likewise, *BgUbc9i* adults also died 1--4 days after the imaginal molt. The similar phenotypes between *BgSUMO1-3i* and *BgUbc9i* animals thus confirm that the defects observed in *BgSUMO1-3i* animals were due to the block of the SUMOylation process. Overall, these results show that SUMOylation has essential roles on *Blattella* viability and metamorphosis, particularly in the control of cell proliferation, developmental timing, and proper molting. F[ig]{.smallcaps}. 5.Depletion of *Blattella BgUbc9* phenocopies the absence of *BgSUMO1* and *BgSUMO3.* (*A*) Dorsal view of newly molted *Control* (left) and *BgUbc9i* (right) adults. Scale bar: 2 mm. (*B*) Details of the adult bristles in *Control* and *BgUbc9i* individuals. Scale bar: 0.5 mm. (*C*) Phenotypic analysis of the forewings (left column), hindwings (central column), and DAPI staining of basal oocytes (right column) of newly molted *Control* and *BgUbc9i* adults. Scale bars: 1 mm (forewings), 2 mm (hindwings), and 5 μm (oocytes). (*D*) Means of maximum length and width of forewings and hindwings, and follicular cell number from basal oocytes of newly molted *Control* and *BgUbc9i* adults. Error bars represent SEM (*n* = 5). Asterisks indicate differences statistically significant as follows: \**P* ≤ 0.05; \*\**P* ≤ 0.001; \*\*\**P* ≤ 0.0005 (*t*-test).

Functional Differences between *Blattella* SUMO Paralogs
--------------------------------------------------------

To assess the contribution of each *BgSUMO* paralog to the observed phenotype, *dsRNAs* targeting each isoform were injected separately into newly emerged penultimate-N5 instar nymphs (*BgSUMO1i* and *BgSUMO3i* animals) (see [supplementary fig. S2*C*](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). These treatments resulted in a remarkable decrease in the corresponding transcript without affecting the expression of the other paralog ([supplementary fig. S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). All the *Control, BgSUMO1i*,** and *BgSUMO3i* animals molted properly to the last-N6 nymphal instar ([supplementary table S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). In contrast to *BgSUMO1-3i* animals injected in N5, all the *Control*, *BgSUMO1i* and *BgSUMO3i* N6 nymphs survived during the metamorphic N6 stage. After that, all the *Control* and *BgSUMO3i* nymphs completed the imaginal molt at the same time ([fig. 6](#msv242-F6){ref-type="fig"}*A* and *B* and [supplementary table S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Likewise, the majority of *BgSUMO1i* animals (74.5%) also reached adulthood although showing a significant developmental delay (mean average for N6 length in *Control* animals: 8.1 ± 0.1 days; in *BgSUMO3i* animals: 7.8 ± 0.14 days; in *BgSUMO1i* animals: 10.46 ± 0.46 days, *P* ≤ 0.0005, Log-Rank test) ([fig. 6](#msv242-F6){ref-type="fig"}*A* and *B* and [supplementary table S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). In contrast, approximately 19% of *BgSUMO1i* animals never reached the adult stage and stayed as nymphs until they died ([fig. 6](#msv242-F6){ref-type="fig"}*A* and *B* and [supplementary table S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Remarkably, although *BgSUMO3i* adults did not show any morphological defects, the phenotype of *BgSUMO1i* animals that molted into adults was identical to that observed in *BgSUMO1-3i* and *BgUbc9i* adults ([fig. 6](#msv242-F6){ref-type="fig"}*B*). The leg bristles in *BgSUMO1i* adults were twisted, indicating molting problems, and the fore- and hindwings were abnormally unfolded and their size was significantly reduced ([fig. 6](#msv242-F6){ref-type="fig"}*B* and *C*). Likewise, the follicular epithelia of *BgSUMO1i* basal oocytes presented a significant impairment of cell division without any increase in cell death, which resulted in a clear reduction in the number of cells ([fig. 6](#msv242-F6){ref-type="fig"}*D* and *E* and [supplementary fig. S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Importantly, *BgSUMO1i* and *BgSUMO3i* adults were fully viable, in contrast to *BgSUMO1-3i* adults, which died soon after the imaginal molt. Altogether, these results show that 1) BgSUMO1 specifically controls SUMO-dependent processes in the metamorphosis and developmental timing of *Blattella*, whereas BgSUMO3 is dispensable in these processes; and 2) both paralogs are redundant for essential SUMOylation-dependent functions related to organism viability. F[ig]{.smallcaps}. 6.BgSUMO1 is the essential paralog in *Blattella* metamorphosis and developmental timing. (*A*) Representation of the timing of imaginal molt in *Control* (blue), *BgSUMO3i* (green), and *BgSUMO1i* animals. *BgSUMO1i* specimens are separated into those that molt to the adult stage (purple) or remained as nymphs (red). (*B*) Dorsal views of *Control* and *BgSUMO3i* specimens 1 day after the imaginal molt, showing normal winged adult shapes (*Control*, left; *BgSUMO3i*, right) and *BgSUMO1i* specimens that remained as nymphs after 14 days (*BgSUMO1i* Nymph 6) or that molt into adults showing defects of wing extension in both the forewings and hindwings (*BgSUMO1i* Adult). Scale bar: 2 mm. (*C*) Phenotypic analysis of the bristles, forewings and hindwings in newly molted *Control*, *BgSUMO1i* and *BgSUMO3i* adults. Scale bars: 0.5 mm (bristles) and 1 mm (forewings and hindwings). Means of maximum length and width of forewings and hindwings in newly molted *Control*, *BgSUMO1i*, and *BgSUMO3i* adults (lower panels). Error bars represent SEM (*n* = 5). Asterisks indicate differences statistically significant as follows: \*\*\**P* ≤ 0.0005 (*t*-test). (*D*) Graphical representation of the mitotic capacity of follicular cells in 5- and 6-day-old *Control* (gray bars), *BgSUMO1i* (red bars) and *BgSUMO1i* N6 nymphs treated with 20E (yellow bars), represented by the number of nuclei marked by the mitotic marker PH3. Asterisks indicate differences statistically significant as follows: \*\*\**P* \< 0.0001. (*n* = 25--30). (*E*) DAPI staining and follicular cell number from basal oocytes in newly molted *Control*, *BgSUMO1i*, and *BgSUMO1i* adults treated with 20E. Scale bar: 5 μm. Error bars represent SEM (*n* = 5--15). Asterisks indicate differences statistically significant as follows: \*\*\**P* ≤ 0.0005 (*t*-test).

BgSUMO1 Is Required for Proper Ecdysteroid Synthesis
----------------------------------------------------

In insects, periodic pulses of the ecdysteroid hormone 20-hydroxyecdysone (20E) at the end of each instar promote the transition to the next stage ([@msv242-B57]). The significant delay in the majority of *BgSUMO1i* nymphs to reach the adult stage, along with the approximately 19% of *BgSUMO1i* nymphs that never reach adulthood, suggested that the biosynthesis of 20E may be defective in these animals. To test this possibility, we measured the levels of 20E in the hemolymph of *Control* and *BgSUMO1i*, as well as in *BgSUMO3i* and *BgSUMO1-3i* animals, during the N6 instar. As [figure 7](#msv242-F7){ref-type="fig"}*A* shows, the levels of circulating 20E in *Control* animals presented the expected peak at the end of the instar. Remarkably, consistent with the strong developmental delay of *BgSUMO1i* nymphs, the circulating 20E titer of these animals was abnormally low compared with *Control* animals ([fig. 7](#msv242-F7){ref-type="fig"}*A*). The levels of 20E eventually increased after a prolonged N6 instar in the *BgSUMO1i* animals that were able to molt into adults (75%) ([fig. 7](#msv242-F7){ref-type="fig"}*A*, purple bar), whereas the increase in 20E levels was not detected in the *BgSUMO1i* nymphs that did not reach adulthood (19%) ([fig. 7](#msv242-F7){ref-type="fig"}*A*, light blue bar). This difference in 20E levels between the two *BgSUMO1i* groups of animals is most likely the result of different RNAi efficiency. Nevertheless, these results show that BgSUMO1 is required for the biosynthesis of 20E in *Blattella*. On the other hand, no differences in 20E levels were found between *Control* and *BgSUMO3i* animals, whereas the increase of circulating 20E in *BgSUMO1-3i* nymphs showed an approximately 1-day delay, also correlating with the developmental delay of these animals ([fig. 7](#msv242-F7){ref-type="fig"}*A*). F[ig]{.smallcaps}. 7.20E biosynthesis and the 20E-signaling response are impaired in *BgSUMO1i* nymphs. (*A*) Ecdysteroid titers in the hemolymph of *Control*, *BgSUMO1i*, and *BgSUMO3i* N6 nymphs determined by ELISA. In *BgSUMO1i* animals, 20E levels are also measured in specimens that molted into adults after a prolonged N6 instar (day 10 molted) and in specimens that remained as nymphs (day 10 not molted). Results are expressed as ng/μl of 20E equivalents. Vertical bars indicate the SEM (*n* = 4). Asterisks indicate differences statistically significant at \**P* ≤ 0.005 (*t*-test). (*B*) Expression levels of the indicated NRs in *Control*, *BgSUMO1i*, *BgSUMO3i,* and *BgSUMO1-3i* nymphs. mRNA levels were analyzed by RT-PCR from prothoracic glands of 6- and 7-day-old last instar nymphs. *BgACTIN-5C* levels were measured as reference. The results shown are representative of five replicates. (*C*) In vitro SUMOylation assay for *Blattella* nuclear receptors BgEcR-A, BgRXR-L, BgE75-A, BgHR3-A, BgHR3-B2, and BgFtz-F1. Proteins were incubated in the absence (−) or presence (+) of human SUMO1. Arrowheads indicate the SUMOylated proteins. Dorsal views of a 20E-treated *BgSUMO1-3i* adult (*D*) and a 20E-treated *BgSUMO1i* adult (*E*) showing defects on wing extension in both the forewings and hindwings. Scale bar: 2 mm. (*F*) Effect of 20E administration to *BgSUMO1-3i* (upper panel) and *BgSUMO1i* animals (lower panel) on the timing of imaginal molt of these animals, compared with *Control* animals. *BgSUMO1i* animals that remained as nymphs were not included in the analysis.

The very low levels of circulating 20E in *BgSUMO1i* nymphs suggest that these animals may have affected the proper temporal progression of the 20E-controlled hierarchy of nuclear hormone receptors (NRs) that directs the transition to the adult stage in *Blattella* ([@msv242-B28]; [@msv242-B11], [@msv242-B12], [@msv242-B14]; [@msv242-B33]; [@msv242-B31], [@msv242-B29]). To test this possibility, we measured the expression of the 20E-dependent NRs in the prothoracic gland of 6- and 7-day-old N6 *Control*, *BgSUMO1i*, *BgSUMO3i* and *BgSUMO1-3i* nymphs, just when the levels of 20E are higher in *Control* animals. As [figure 7](#msv242-F7){ref-type="fig"}*B* shows, mRNA levels of *BgEcR-A* and *BgRXR*, which form the 20E heterodimeric receptor, were normal in *BgSUMO1i*, *BgSUMO3i,* and *BgSUMO1-3i* nymphs. In contrast, the sequential expression of three NRs that are induced by the increasing levels of 20E, namely *BgE75A*, *BgHR3-A* and *BgFTZ-F1*, was completely halted in *BgSUMO1i* nymphs when compared with *Control*, *BgSUMO3i,* and *BgSUMO1-3i* animals. Accordingly, the transcript levels of *BgE75C*, an NR that is expressed at low levels of 20E and repressed at high levels of this hormone, were very high in *BgSUMO1i* nymphs, whereas it was undetectable in *Control, BgSUMO3i*,** and *BgSUMO1-3i* nymphs ([fig. 7](#msv242-F7){ref-type="fig"}*B*). It is interesting to note that the lower expression levels of *BgHR3-A* and *BgFTZ-F1* in *BgSUMO1-3i* nymphs are consistent with the delay in the increase of 20E levels observed in these animals. Taken together, these results show that BgSUMO1 is required for the proper synthesis of 20E and, therefore, for the correct transduction of the hormonal signaling. In *Drosophila*, *Smt3* is also essential for 20E biosynthesis and signaling in the prothoracic gland during the last larval stage ([@msv242-B47]). In this gland, Smt3 controls the expression and transcriptional activity of Ftz-f1 and regulates cholesterol intake through controlling the expression of *Scavenger receptors* (*SR-BI*) ([@msv242-B46]). Furthermore, Smt3 is essential for maintaining the Ultraspiracle (USP) protein levels (the RXR ortholog in *Drosophila*) and USP SUMOylation is required for full 20E-induced activity in the fly ([@msv242-B54]). Therefore, it is plausible that, in addition to the 20E-biosynthesis defect, the missregulation of the 20E-signaling cascade observed in *BgSUMO1i* animals is also partially provoked by deficient SUMOylation of the NRs that transduce the hormonal signal. Supporting this possibility, we have found that the *Blattella* 20E-dependent NRs analyzed, including BgRXR and BgEcR, are SUMOylated in vitro ([fig. 7](#msv242-F7){ref-type="fig"}*C*).

To further determine to what extent the metamorphic defects, developmental retardation and viability impairment in *BgSUMO-1i* and *BgSUMO1-3i* animals are caused by defective 20E biosynthesis, we injected 20E to 5-day-old *BgSUMO-*depleted nymphs, just when the levels of 20E start to increase in *Control* nymphs. This procedure is an established approach used to examine the role of 20E in 20E-defective *Blattella* nymphs ([@msv242-B31]). Interestingly, the adult morphological defects of *BgSUMO1i* and *BgSUMO1-3i* animals were not rescued ([fig. 7](#msv242-F7){ref-type="fig"}*D* and *E*). 20E also failed to rescue the proliferation capacity of the follicular cells of *BgSUMO1i* and *BgSUMO1-3i* animals, nor increased the cell death of these cells ([figs. 4](#msv242-F4){ref-type="fig"}*E,* [4](#msv242-F4){ref-type="fig"}*F,* [6](#msv242-F6){ref-type="fig"}*D*, and [6](#msv242-F6){ref-type="fig"}*E* and [supplementary fig. S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online). Likewise, supplying 20E did not rescue the viability of *BgSUMO1-3i* adults, as they also died 1--4 days after the imaginal molt. In contrast, supplement of 20E completely rescued the developmental delay in the N6-adult transition in *BgSUMO1i* and *BgSUMO1-3i* animals ([fig. 7](#msv242-F7){ref-type="fig"}*F*). Altogether, these results show that BgSUMO1 not only exerts critical regulatory activities through the regulation of 20E biosynthesis (developmental timing) but also acts in a 20E-independent manner (cell proliferation, molting, and adult viability).

In summary, our paralog-specific RNAi analyses indicate that *BgSUMO1* is essential for *Blattella* metamorphosis, particularly in cell proliferation, 20E biosynthesis and signaling response, developmental timing and molting, whereas *BgSUMO3* is dispensable in these processes. In vertebrates, most of the SUMOylation substrates are uniquely or preferentially modified by a specific paralog in normal conditions and only a certain overlap (∼15%) has been demonstrated ([@msv242-B32]; [@msv242-B42]; [@msv242-B53]). Despite this specificity, the lack of SUMO1 promotes compensatory SUMOylation with SUMO2/3, suggesting certain redundancy in their functions ([@msv242-B58]; [@msv242-B9]). Consistent with this observation, SUMO1 is dispensable in zebrafish and mice development ([@msv242-B59]; [@msv242-B58]). In contrast, our results demonstrate that BgSUMO3 cannot compensate the absence of BgSUMO1 during *Blattella* metamorphosis, uncovering the occurrence of paralog-specific functions in insects with two SUMO paralogs.

*Blattella* BgSUMO3 Paralog Can Substitute for *Drosophila* Smt3
----------------------------------------------------------------

The results above indicate that, although the role of SUMOylation in insect metamorphosis is evolutionarily conserved, this function has switched from SUMO1 in basal orders of insects (*Blattella*) to SUMO3 in more derived holometabolous insects (*Drosophila*). To further characterize this evolutionary switch, we asked whether *Blattella* BgSUMO1 could functionally substitute for *Drosophila* Smt3 in the control of a SUMO-dependent process, namely the development of *Drosophila* wing. Growth and patterning in *Drosophila* wings are highly stereotypical processes and any variation in the size and the location of the longitudinal veins is easily detectable ([fig. 8](#msv242-F8){ref-type="fig"}*A*). Thus, the depletion of Smt3 from the central part of the wing (*smt3i* wings) by using the *Sal^EPv^-GAL4* driver provoked smaller wings and affected the formation of the intervein region between LII and LIII veins ([fig. 8](#msv242-F8){ref-type="fig"}*B* and *G*). In this *smt3i* background, the overexpression of *Blattella BgSUMO1* did not rescue the wing deficiencies ([fig. 8](#msv242-F8){ref-type="fig"}*C* and *G*), whereas the overexpression of *BgSUMO3* restored perfectly the wing size and the integrity of the LII--LIII intervein region ([fig. 8](#msv242-F8){ref-type="fig"}*D* and *G*). To confirm these results, we turned to the prothoracic gland as a model tissue. The downregulation of *smt3* in the prothoracic gland by using the *phantom-GAL4* driver prevents larvae from entering pupariation ([table 1](#msv242-T1){ref-type="table"}), due to the inability to produce the 20E pulse that induces metamorphosis ([@msv242-B47]). Consistent with the results obtained in the wings, the overexpression of *BgSUMO1* in *smt3*-depleted prothoracic glands was not able to rescue the *smt3i* phenotype, whereas the overexpression of *BgSUMO3* completely rescued the pupariation phenotype, resulting in normal adult flies ([table 1](#msv242-T1){ref-type="table"}). Altogether, these results indicate that although BgSUMO1 is the crucial SUMO paralog in the metamorphosis of basal insects, it cannot substitute for Smt3 in *Drosophila* development, most probably due to the low sequence similarity. Conversely, BgSUMO3, which is dispensable in *Blattella* metamorphosis, contains all the elements necessary to function properly in *Drosophila*. F[ig]{.smallcaps}. 8.Functional analysis of *Blattella* and human SUMOs in *Drosophila*. (*A*) Control wing. Green area represents *Sal^EPv^-Gal4* expression domain. LII--LIII intervein region (arrowhead) and longitudinal veins II--V are indicated. (*B*) Wing silenced for *smt3* (smt3i), showing surface reduction on LII--LIII intervein region. (*C*) Wing silenced for *smt3* that simultaneously overexpresses *Blattella BgSUMO1*, which cannot rescue Smt3 absence. (*D*) Wing silenced for *smt3* that simultaneously overexpresses *Blattella BgSUMO3*, which rescues the absence of Smt3 and recuperates the LII--LIII intervein region. (*E*) Wing silenced for *smt3* that simultaneously overexpresses human *SUMO3*, showing stronger deficiencies than smt3i wings (*B*). (*F*) Wing overexpressing human *SUMO3* in a WT background. Wings are smaller than control and present ectopic veins (black arrowhead), confirming the adverse effect of human SUMO3 on wing development. (*G*) Analysis of the wing area under the aforementioned conditions. Error bars represent SEM (*n* = at least 15 wings). Asterisks indicate differences statistically significant as follows: \*\*\**P* ≤ 0.0005 (*t*-test). Table 1.Phenotypic Effect of *BgSUMO1* or *BgSUMO3* Overexpression in Prothoracic Glands of *smt3i Drosophila* Larvae.Adults (%)Larval Arrest (%)+;+100---smt3i;+---100smt3i;BgSUMO1---100smt3i;BgSUMO3100---

If sequence similarity between BgSUMO3 and *Drosophila* Smt3 is important to allow proper SUMOylation, then it would be expected that human SUMO3, with a sequence that is also highly similar to Smt3 ([fig. 1](#msv242-F1){ref-type="fig"}*B* and *C*), might be able to rescue the *smt3i* phenotypes in *Drosophila*. However, contrary to *Drosophila* Smt3 and *Blattella* SUMO3, human SUMO3 protein can form polySUMO chains efficiently and differs from the others in its N-terminal sequence ([figs. 1](#msv242-F1){ref-type="fig"}*C* and [2](#msv242-F2){ref-type="fig"}*A*). This difference allows us to analyze in insects the functional implication of the N-terminal region of the SUMOs. Toward this aim, we performed rescue experiments overexpressing human *SUMO3* in *smt3*-depleted wings (*smt3i*;SUMO3). Interestingly, we observed that human SUMO3 did not rescue the absence of *Drosophila* Smt3 despite their high sequence homology ([fig. 8](#msv242-F8){ref-type="fig"}*E* and *G*). In fact, the phenotype observed in *smt3i*;SUMO3 wings was stronger than that observed in *smt3i* animals, indicating that human SUMO3 has a deleterious effect in *Drosophila*. Consistently, the overexpression of human *SUMO3* in a wild-type background (GFP;SUMO3) resulted in smaller wings with ectopic veins ([fig. 8](#msv242-F8){ref-type="fig"}*F* and *G*). Altogether, our results suggest that the N-terminal region of human SUMO3 is detrimental in insects. This feature represents an important evolutionary difference with vertebrates, including the capacity to form polySUMO chains, which are essential for several key processes, such as cellular stress response and ubiquitin-dependent degradation of damaged proteins by proteasome ([@msv242-B43]; [@msv242-B8]). PolySUMOylated proteins are recognized by the SUMO-targeted ubiquitin ligase RNF4, which in turn ubiquitylates the substrate and targets it for proteasome degradation ([@msv242-B49]). The RNF4 ortholog in *Drosophila*, Degringolade, can recognize and ubiquitylate SUMOylated and non-SUMOylated proteins, targeting them for degradation ([@msv242-B1]). However, consistent with the insect inability to form SUMO chains, Degringolade null mutants are viable ([@msv242-B3]). Interestingly, SUMO chain formation is neither essential in yeast, as mutation of the SUMOylable lysines in *Saccharomyces* Smt3 (K11, K15, and K19) impairs formation of chains but does not affect viability, growth or stress sensitivity ([@msv242-B7]). These data suggest that the essential roles controlled by polySUMO chains could be an innovative feature of vertebrates, although SUMO orthologs from other animal species should be studied to confirm this hypothesis.

Finally, based on our results we conclude the following: 1) The duplication of the ancestral *SUMO* gene occurred at the base of Metazoan evolution. Hence, basal insects possess two *SUMO* genes, encoding for SUMO1 and SUMO3 paralogs. However, during insect evolution the *SUMO1* gene has been lost after the hymenopteran divergence, and, as a result, Coleopteran, Lepidopteran and Dipteran species have only the *SUMO3* gene. 2) Despite the difference in the number of *SUMO* genes, the role of SUMOylation in the control of metamorphosis is conserved in hemimetabolous and holometabolous insects. 3) The processes regulated by SUMOylation in *Blattella* metamorphosis (cell proliferation, ecdysone signaling response, and proper molting) are specifically controlled by the SUMO1 paralog. In contrast, SUMO1 and SUMO3 exert redundant functions in *Blattella* viability. 4) During insect evolution, derived holometabolous insects (*Drosophila*) have co-opted SUMO3 for all the metamorphic functions that are controlled specifically by the SUMO1 paralog in more basal insects (*Blattella*). This switch has probably allowed the loss of *SUMO1* gene in the derived holometabolan species. 5) The sequence and structure differences between SUMO1 and SUMO3 paralogs are crucial for their biological roles, as *Blattella* SUMO1 protein cannot functionally substitute for *Drosophila* Smt3 in the control of SUMO-dependent processes during the metamorphosis of the fly, despite being the critical paralog in *Blattella* metamorphosis. In contrast, *Blattella* SUMO3 paralog, which is dispensable in the cockroach metamorphosis, contains all the elements necessary to substitute *Drosophila* Smt3. 6) Unlike SUMO3 from vertebrates, insect SUMO3 proteins have lost the capacity to form polySUMO chains due to the loss of key lysine residues within their flexible and disorganized N-terminal part. In addition, and given that *Blattella* SUMO1 protein is only residually polySUMOylated in vitro, we conclude that insect SUMO proteins cannot form polySUMO chains.

Materials and Methods
=====================

Insects
-------

*Blattella* specimens were reared in the dark at 30 ± 1°C and 60--70% relative humidity. *Drosophila* were raised on standard medium at 25°C. Knockdown and overexpression experiments were performed using the GAL4/UAS system ([@msv242-B6]). *phantom-Gal4*,UAS-mCD8::GFP/TM6B,Tb strain was obtained from P. Leopold and C. Mirth ([@msv242-B10]; [@msv242-B35]). Other strains used were *Sal^EPv^-Gal4* ([@msv242-B2]) and UAS-RNAi line *UAS-smt3i* ([@msv242-B47]). *UAS-BgSUMO1*, *UAS-BgSUMO3*,** and *UAS-SUMO3* strains were generated as described below.

Plasmid Construction and Generation of Transgenic Strains
---------------------------------------------------------

*BgSUMO1* (EMBL: LN809887), *BgSUMO3* (EMBL: LN809888), and human *SUMO3* (EMBL: NM006936) coding regions were amplified using the specific primers described in [supplementary table S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online. Fragments obtained were subsequently cloned into the *Eco*RI--*Xho*I sites (*BgSUMO1* and *BgSUMO3*) or into the *Bgl*II--*Xho*I sites (human *SUMO3*) of *pUASTattb* vector ([@msv242-B5]). Transgenic lines were generated following standard transformation procedures ([@msv242-B44]).

Cloning of *Blattella* BgSUMO1, BgSUMO3, and BgUbc9 cDNAs
---------------------------------------------------------

The two full length cDNA clones corresponding to *BgSUMO1* and *BgSUMO3* were obtained from a suppression subtractive hybridization library that was carried out using the polymerase chain reaction (PCR)-selected cDNA Subtraction Kit (Clontech), following the manufacturer's protocols. The tester library was prepared with 1 μg of polyA + mRNA from UM-BGE-1 embryonic cells from *Blattella* treated with 20E during 10 h. The driver library was prepared with the same amount of polyA + mRNA from untreated UM-BGE-1 cells. The *BgUbc9* cDNA clone was isolated by PCR using cDNA template from prothoracic glands of *Blattella* last instar nymphs. Total RNA was isolated using GenElute Mammalian Total RNA kit (Sigma) and DNase-treated with RQ1 RNase-Free DNase (Promega). The cDNA was generated by reverse transcription with Transcriptor First Strand cDNA Synthesis Kit (Roche) as previously described ([@msv242-B28]; [@msv242-B11]). The sequence of *BgUbc9* homolog was obtained by PCR using degenerate primers: Fw 5′-TGGMGNAARGANCAYCC-3′ and Rv 5′-ACNCKYTTNTCRTAYTC-3′. A 398-bp fragment was amplified, subcloned into the pSTBlue-1 vector (Novagen), and sequenced. This was followed by 5′- and 3′-RACE Rapid amplification of cDNA ends (RACE) (5′- and 3′-RACE System Version 2.0; Invitrogen) to obtain the full *BgUbc9* coding region, using the specific primers described in [supplementary table S6](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online. All PCR products were subcloned into pSTBlue-1 vector (Novagen) and sequenced in both directions. A final 654-bp fragment of *BgUbc9* gene covering full coding region was obtained (EMBL: LN809889).

Semiquantitative Reverse Transcriptase PCR
------------------------------------------

Total RNA was extracted from different tissues using the GenElute Mammalian Total RNA Kit (Sigma), and equivalent amounts of RNA were used for cDNA synthesis as described above. Reverse transcriptase (RT)-PCR without reverse transcription was used to confirm the absence of genomic contamination. All PCR amplifications were carried out using GoTaq DNA Polymerase (Promega) following manufacturer's instructions. As a reference, *Blattella BgActin-5C* expression levels were measured in each cDNA sample. Primer sequences used for RT-PCR are described in [supplementary table S7](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online.

Quantitative Real-Time RT-PCR
-----------------------------

Total RNA from three staged prothoracic glands was isolated and retrotranscribed as described above. Relative transcript levels were determined using Power SYBR Green PCR Mastermix (Applied Biosystems). To standardize the quantitative real-time RT-PCR (qPCR) inputs, a master mix that contained Power SYBR Green PCR Mastermix and forward and reverse primers was prepared to a final concentration of 100 nM for each primer. The qPCR experiments were conducted with the same quantity of organ equivalent input for all treatments, and each sample was run in duplicate using 2 µl of cDNA per reaction. All the samples were analyzed on the iCycler iQReal Time PCR Detection System (Bio-Rad). For each standard curve, one reference DNA sample was diluted serially. Primer sequences used for qPCR are described in [supplementary table S8](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online.

RNAi Synthesis and Injection
----------------------------

RNAi in vivo in nymphs of *Blattella* was performed as previously described ([@msv242-B33]; [@msv242-B12]). A volume of 1 µl of each *dsRNA* solution (4 µg/µl) was injected into the abdomen of newly emerged female nymphs. In case of coinjection of two *dsRNAs* (*dsBgSUMO1* and *dsBgSUMO3*), 0.5 μl of each solution was applied in a single injection of 1 μl (2 μg/μl each *dsRNA*). In case of injections to newly emerged fifth-instar nymphs, the animals were reinjected just after molting to the subsequent nymphal instar. Control *dsRNA* (*dsMock*) consisted of a noncoding sequence from the pSTBlue-1 vector ([@msv242-B11]). Primers used to generate construct templates for *dsRNA* synthesis are described in [supplementary table S9](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online.

Treatments In Vivo with 20E
---------------------------

N6 nymphs were injected at day 5 with 20 μg of 20E (Sigma) per specimen in 1 μl of Ringer saline with 10% ethanol. Controls received the same volume of solvent.

Quantification of Circulating Ecdysteroids
------------------------------------------

Hemolymph ecdysteroids were quantified by enzyme-linked immunosorbent assay (ELISA) as previously described ([@msv242-B13]). 20E (Sigma) and 20E-acetylcholinesterase (Cayman Chemical, Ann Arbor, MI) were used as a standard and an enzymatic tracer, respectively. The antiserum (Cayman Chemical) was used at a dilution of 1:50,000. Absorbances were read at 450 nm, using a Multiscan Plus II Spectrophotometer (Labsystems, Madrid, Spain). The ecdysteroid antiserum used has the same affinity for ecdysone and 20E, but as the standard curve was obtained with the later compound, results are expressed as 20E equivalents.

Microscopy and Immunocytochemistry
----------------------------------

All dissections of *Blattella* nymphal and adult tissues were carried out in Ringer's saline on carbon dioxide-anesthetized specimens. Ovaries were fixed in 4% paraformaldehyde, permeabilized in Phosphate-buffered saline (PBS)--0.2% Tween (PBT), and incubated for 10 min in 1 μg/ml DAPI4\', 6\'-Diamidino-2-phenylindole (DAPI) in PBT. After two washes with PBT, ovaries were mounted in Mowiol 4-88 (Calbiochem). For immunocytochemistry analysis, anti-pH3 (Ser10) and anti-Caspase 3 antibodies (Cell Signaling Technologies) were used to analyze cell proliferation and cell death, respectively. Ovaries were fixed in 4% paraformaldehyde, permeabilized in PBS--0.1% Triton 30 min, and incubated 2 h with anti-pH3 (dilution 1:100) or anti-Caspase 3 (dilution 1:250) antibodies. After washing, ovaries were incubated 2 h with antirabbit secondary antibody, counterstained with DAPI, and mounted in Vectashield Mounting Medium for Fluorescence H-1000 (Vector Laboratories). All samples were examined with an AxioImager.Z1 (ApoTome 213 System; Zeiss) microscope and images were subsequently processed using Adobe Photoshop. To calculate the number of follicular cells, basal oocytes stained with DAPI were used. The oocyte surface was measured with the formula: Oocyte surface = 4π · (length/2) · (width/2). Total number of follicular cells (*N*) was determined after counting the number of nucleus present in a square (*n*) and extrapolating the value to the entire oocyte through the formula: *N* = (oocyte surface · n)/square surface. Maximum length and width of forewings and hindwings were measured in Adobe Photoshop from images taken with Zeiss SteREO Discovery.V8 and AxioCam MRc5.

In Vitro SUMOylation and SUBE Assays
------------------------------------

*Drosophila*, *Blattella*, and human *SUMOs* were amplified using the primers described in [supplementary table S10](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online. Each primer contains the T7 promoter sequence in the 5′-end followed by the sequence of HA tag. For SUMOylation of the *Blattella* nuclear receptors, the following cDNAs were used: *BgEcR-A* (EMBL: AM039690), *BgRXR-L* (EMBL: AJ854490), *BgE75-A* (EMBL: AM238653), *BgHR3-A* (EMBL: AM259128), *BgHR3-B2* (EMBL: AM259130), and *BgFtz-F1* (EMBL: FM163377). The products of amplification, or the cDNAs used as templates, were translated using TNT Wheat Germ extract (Promega) and, in the case of *Blattella* nuclear receptors, ^35^S-methionine (Amersham Biosciences and Pierce). All proteins were incubated in a buffer containing an ATP regenerating system (50 mM Tris pH 7.5, 10 mM MgCl~2~, 2 mM ATP, 10 mM creatine phosphate \[Sigma\], 3.5 U/ml of creatine kinase \[Sigma\], and 0.6 U/ml of inorganic pyrophosphatase \[Sigma\]), SUMO1 (for nuclear receptors) or SUMO2 and SUMO3 (for SUMO proteins) (5 µg each), Ubc9 (0.325 µg), and purified SAE1/2 (0.8 µg; ENZO Life Sciences). Reactions were incubated at 30°C for 2 h, resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and exposed.

For SUBE pulldown assays, one-tenth of input was saved and the rest of the reaction was incubated with 50 µl of Glutathione S-Transferase (GST)-agarose beads containing 50 µg of SUBEs or GST (data not shown) and 1 mM Dithiothreitol (DTT) for 2 h at 4 °C. After incubation, beads were pulled down by centrifugation and one-tenth of the unbound fraction was kept for western analysis. Subsequently, the same beads were washed with the binding buffer (50 mM Tris pH 8.5; 50 mM NaCl, 5 mM ethylenediaminetetraacetic acid, and 1% Igepal) and were resuspended in Laemmli Buffer before being loaded on a 12% SDS-PAGE.

Phylogenetic Analysis
---------------------

For the phylogenetic analyses, we used the sequences detailed in [supplementary file S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) online. Protein sequences were aligned using ClustalX ([@msv242-B51]) or MAFFT with default parameters ([@msv242-B25]) and alignment-ambiguous regions were removed. The resulting alignment (99 positions) was analyzed by the PhyML program ([@msv242-B20]), based on the maximum-likelihood principle with the model of amino acid substitution. The data sets were bootstrapped for 100 replicates using PhyML. In the phylogenetic analysis with all eukaryote SUMO sequences, the tree was rooted by the plants.

Structural Analysis
-------------------

Among the different three-dimensional structures available at the Protein Data Bank (PDB), those corresponding to the isolated SUMO proteins (not bound to other proteins) and spanning the longest amino acid sequences were chosen for comparison: HsSUMO2 (PDB: 2AWT), HsSUMO3 (PDB: 1U4A), and DmSmt3 (PDB: 2K1F). All three are solution Nuclear magnetic resonance (NMR) structures represented by ensembles of 20 models, and one model from each ensemble was used for the superposition shown in [figure 1](#msv242-F1){ref-type="fig"}*B*. Because the N- and C-terminal ends were found disordered and flexible, superposition was based only on the well-defined regions (residues 18--90 of HsSUMO2, residues 17--89 of HsSUMO3, and residues 13--85 of DmSmt3) as seen in the ensembles. The superposition and the [figure 1](#msv242-F1){ref-type="fig"}*B* were made with PyMol. The alignment with the secondary structure elements of DmSmt3 on top of it was prepared with ESPRIPT ([@msv242-B19]).

Statistical Analysis
--------------------

pH3 data were analyzed by using the R environment ([@msv242-B41]). The normal distributions were performed using the Shapiro--Wilk test (R function Shapiro.test). The statistical significance of values between three groups was evaluated by ANOVA (analysis of variance) test followed by Bonferroni's Honestly Significant Difference post hoc test. pH3 graphs were generated in R using a custom script based on the base boxplot function superimposed with individual data points plotted with the beeswarm function (package beeswarm).

Supplementary Material
======================

[Supplementary file S1, figures S1--S5](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1), and [tables S1--S10](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv242/-/DC1) are available at *Molecular Biology and Evolution* online (<http://www.mbe.oxfordjournals.org/>).
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